Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Bombesin Receptors
More Information »Bombesin receptors are activated by the endogenous ligands gastrin-releasing peptide (GRP), neuromedin B (NMB) and GRP18-27 (neuromedin C). Three subtypes of bombesin receptor are known: BB1, BB2 and an orphan receptor (bb3).
Bombesin Receptor Products
Agonists |
|
Cat.No. |
Product Name / Activity |
| 2716 | BIM 187 |
| Bombesin/GRP receptor agonist | |
| 1149 | Bombesin |
| Involved in gastrointestinal tract function | |
| 1789 | GRP (human) |
| Endogenous GRP receptor agonist | |
| 1788 | GRP (porcine) |
| Endogenous GRP receptor agonist | |
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 2717 | BIM 189 |
| Bombesin antagonist | |
| 3237 | BIM 23042 |
| Selective neuromedin B receptor antagonist (NMB-R, BB1) | |
| 1839 | BIM 23127 |
| NMB receptor antagonist. Also U-II receptor antagonist | |
| 1913 | [D-Phe12]-Bombesin |
| Bombesin receptor antagonist | |
| 3422 | [D-Phe12,Leu14]-Bombesin |
| Bombesin receptor antagonist | |
| 2602 | PD 176252 |
| GRP (BB2) and NMB (BB1) receptor antagonist | |
Other |
|
Cat.No. |
Product Name / Activity |
| 1893 | Alytesin |
| Amphibian bombesin-like peptide | |
| 1916 | Litorin |
| Amphibian bombesin-like peptide | |
| 1908 | Neuromedin B (porcine) |
| Mammalian bombesin-like peptide | |
| 1890 | Neuromedin C (porcine) |
| Mammalian bombesin-like peptide | |
Quick Order
Find multiple products by catalog number
Appetite Modulation
Written by Sonia A. Tucci, Lynsay Kobelis & Tim Kirkham. Request a copy or view PDF today.
Gut Hormones and the Regulation of Appetite
Written by V.J. Taylor et al
'Gut Hormones and the Regulation of Appetite' summarizes the neuropeptide modulators and gut hormones that influence appetite
7-TM Receptor Signaling
Written by T. Kenakin et al
'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.